These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 688)

  • 61. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
    Lare MS; Smith LH
    J Med Chem; 1982 Nov; 25(11):1286-92. PubMed ID: 6128420
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
    Shibouta Y; Nishikawa K; Kikuchi S; Shimamoto K
    Eur J Pharmacol; 1979 Jan; 53(2):201-8. PubMed ID: 759198
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 64. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 66. [Analysis of the effect of exaprolol on bronchospasm in guinea pigs (author's transl)].
    Babul'ová A; Buran L
    Bratisl Lek Listy; 1981 Oct; 76(4):471-80. PubMed ID: 6117354
    [No Abstract]   [Full Text] [Related]  

  • 67. Differentiation of metabolic adrenoceptors.
    Loakpradit T; Lockwood R
    Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 69. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparative study of the beta-adrenergic blocking properties of aroxyalkanolamine derivatives].
    Gorodinskaia VIa; Berzon ETs; Frantsuzova SB; Shchenchenko ZP
    Farm Zh; 1976; (4):63-7. PubMed ID: 12002
    [No Abstract]   [Full Text] [Related]  

  • 71. Bêta-adrenoreceptor blocking properties of 1-nitro, hydroxy phenyl, N-benzoyl alanine (GAL-1).
    Telang B; Galzigna L
    Agressologie; 1976; 17(1):43-8. PubMed ID: 9003
    [No Abstract]   [Full Text] [Related]  

  • 72. [A search for new beta-adrenoblockaders in the series of 5-phenoxymethyl-1,2,4-oxadiazole derivatives].
    Mashkovskiĭ MD; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):27-30. PubMed ID: 7914114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
    Westheim AS; Christensen CC; Kjekshus J
    Eur J Clin Pharmacol; 1978 May; 13(3):157-62. PubMed ID: 27370
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmacological studies of scorpion (Androctonus amoreuxi Aud. & Sav.) venom.
    Ghazal A; Ismail M; Abdel-Rahman AA; El-Asmar MF
    Toxicon; 1975 Aug; 13(4):253-9. PubMed ID: 1166465
    [No Abstract]   [Full Text] [Related]  

  • 75. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.
    Adam KR; Baird JR; Burges RA; Linnell J
    Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851
    [No Abstract]   [Full Text] [Related]  

  • 76. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacologic analysis of chronotropic and inotropic responses to 5-hydroxytryptamine in the dog heart.
    Chiba S
    Jpn J Pharmacol; 1977 Oct; 27(5):727-34. PubMed ID: 22772
    [No Abstract]   [Full Text] [Related]  

  • 78. An attempt at blocking the cardiovascular and metabolic side-effects of beta-mimetic drugs during labor.
    Esteban-Altirriba J; Reñé AM; Durán P; Cabero L; Giralt E; Carreras M; García-Cambronero MT
    J Perinat Med; 1974; 2(4):243-53. PubMed ID: 4468312
    [No Abstract]   [Full Text] [Related]  

  • 79. [p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agents.
    Bouley E; Teulon JM; Cazes M; Cloarec A; Deghenghi R
    J Med Chem; 1986 Jan; 29(1):100-3. PubMed ID: 3001305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aggravation of the severity of the clonidine withdrawal syndrome in conscious rats by beta 2-adrenoceptor antagonists.
    Jonkman FA; van Zwieten PA
    Drugs; 1990; 40 Suppl 4():45-7. PubMed ID: 1982655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.